[1] Roumeliotis S, Roumeliotis A, Dounousi E,et al.Biomarkers of vascular calcification in serum[J]. Adv Clin Chem,2020,98:91-147. [2] Montaigne D, Butruille L, Staels B.PPAR control of metabolism and cardiovascular functions[J]. Nat Rev Cardiol, 2021, 18(12): 809-823. [3] Phadwal K, Feng D, Zhu D, et al.Autophagy as a novel therapeutic target in vascular calcification[J]. Pharmacol Ther, 2020, 206:107430. [4] 王亚萍,何胜虎.过氧化体增殖物激活型受体γ抑制转化生长因子β1诱导的血管平滑肌细胞钙化[J].中国动脉硬化杂志. 2018,26(12):1206-1211. [5] Neutel CHG, Hendrickx JO, Martinet W, et al.The Protective Effects of the Autophagic and Lysosomal Machinery in Vascular and Valvular Calcification: A Systematic Review[J]. Int J Mol Sci,2020,21(23):8933. [6] Frauscher B, Kirsch AH, Schabhüttl C, et al.Autophagy Protects From Uremic Vascular Media Calcification[J]. Front Immunol,2018 ,9:1866. [7] Singh A, Tandon S, Tandon C.An update on vascular calcification and potential therapeutics[J]. Mol Biol Rep,2021,48(1):887-889. [8] Quaglino D, Boraldi F, Lofaro FD.The biology of vascular calcification[J]. Int Rev Cell Mol Biol,2020,354:261-353. [9] Liang Y, Chen G, Zhang F, et al.Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway[J]. Antioxidants (Basel),2021 ,10(6):916. [10] Reinhold S, Blankesteijn WM, Foulquier S.The Interplay of WNT and PPARγ Signaling in Vascular Calcification[J]. Cells, 2020, 9(12): 2658. [11] Faghfouri AH, Khajebishak Y, Payahoo L, et al.PPAR-gamma agonists: Potential modulators of autophagy in obesity[J]. Eur J Pharmacol, 2021, 912:174562. |